These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37463414)

  • 21. Economic Costs of Diabetes in the U.S. in 2022.
    Parker ED; Lin J; Mahoney T; Ume N; Yang G; Gabbay RA; ElSayed NA; Bannuru RR
    Diabetes Care; 2024 Jan; 47(1):26-43. PubMed ID: 37909353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Projecting Long-term Health and Economic Burden of COPD in the United States.
    Zafari Z; Li S; Eakin MN; Bellanger M; Reed RM
    Chest; 2021 Apr; 159(4):1400-1410. PubMed ID: 33011203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor vehicle safety, health care, and taxes. National Highway Traffic Safety Administration, U.S. Department of Transportation.
    Prehosp Disaster Med; 1994; 9(1):11-23. PubMed ID: 10155483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G
    Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics.
    Singal AK; Arsalan A; Dunn W; Arab JP; Wong RJ; Kuo YF; Kamath PS; Shah VH
    Aliment Pharmacol Ther; 2021 Aug; 54(4):451-461. PubMed ID: 34247424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Economic Burden of Adults with Major Depressive Disorder in the United States (2019).
    Greenberg P; Chitnis A; Louie D; Suthoff E; Chen SY; Maitland J; Gagnon-Sanschagrin P; Fournier AA; Kessler RC
    Adv Ther; 2023 Oct; 40(10):4460-4479. PubMed ID: 37518849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health and economic burden due to alcohol-associated liver diseases in the Union Territory of Delhi: A Markov probabilistic model approach.
    Ramalingam A; Pasupuleti SSR; Nagappa B; Sarin SK
    Indian J Gastroenterol; 2022 Feb; 41(1):84-95. PubMed ID: 35226293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
    Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
    Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geographic Density of Gastroenterologists Is Associated With Decreased Mortality From Alcohol-Associated Liver Disease.
    Lee BP; Dodge JL; Terrault NA
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1542-1551.e6. PubMed ID: 35934291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic costs of excessive alcohol consumption in the U.S., 2006.
    Bouchery EE; Harwood HJ; Sacks JJ; Simon CJ; Brewer RD
    Am J Prev Med; 2011 Nov; 41(5):516-24. PubMed ID: 22011424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focus on alcoholic liver disease: from nosography to treatment.
    Streba LA; Vere CC; Streba CT; Ciurea ME
    World J Gastroenterol; 2014 Jul; 20(25):8040-7. PubMed ID: 25009375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The societal economic burden of autosomal dominant polycystic kidney disease in the United States.
    Cloutier M; Manceur AM; Guerin A; Aigbogun MS; Oberdhan D; Gauthier-Loiselle M
    BMC Health Serv Res; 2020 Feb; 20(1):126. PubMed ID: 32070341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Economic Burden of Asthma in the United States, 2008-2013.
    Nurmagambetov T; Kuwahara R; Garbe P
    Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persons with chronic conditions. Their prevalence and costs.
    Hoffman C; Rice D; Sung HY
    JAMA; 1996 Nov; 276(18):1473-9. PubMed ID: 8903258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020.
    Ford ES; Murphy LB; Khavjou O; Giles WH; Holt JB; Croft JB
    Chest; 2015 Jan; 147(1):31-45. PubMed ID: 25058738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intersection of Coronavirus Disease 2019 and Alcohol-associated Liver Disease: A Review of Emerging Trends and Implications.
    Aby ES; Vogel AS; Winters AC
    Clin Ther; 2023 Dec; 45(12):1164-1170. PubMed ID: 37758533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States.
    Gao X; Lv F; He X; Zhao Y; Liu Y; Zu J; Henry L; Wang J; Yeo YH; Ji F; Nguyen MH
    J Hepatol; 2023 Jan; 78(1):16-27. PubMed ID: 35988691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial and ethnic disparities in alcohol-associated liver disease in the United States: A systematic review and meta-analysis.
    Anouti A; Seif El Dahan K; Rich NE; Louissaint J; Lee WM; Lieber SR; Arab JP; Zhang BY; Patel MJ; Thimphittaya C; Díaz LA; Gregory DL; Kozlitina J; VanWagner LB; King AC; Mitchell MC; Singal AG; Cotter TG
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38497931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing the Global Burden of Alcohol-Associated Liver Disease: A Blueprint for Action.
    Asrani SK; Mellinger J; Arab JP; Shah VH
    Hepatology; 2021 May; 73(5):2039-2050. PubMed ID: 32986883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.